One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals

Persistent symptoms of SARS‐CoV‐2 are prevalent weeks to months following the infection. To date, it is difficult to disentangle the direct from the indirect effects of SARS‐CoV‐2, including lockdown, social, and economic factors.

[1]  Janet Diaz,et al.  A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.

[2]  P. Auwaerter.  The Race to Understand Post–COVID-19 Conditions , 2021, Annals of Internal Medicine.

[3]  Ting Yu,et al.  1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study , 2021, The Lancet.

[4]  P. Edison,et al.  Long covid—mechanisms, risk factors, and management , 2021, BMJ.

[5]  I. Guessous,et al.  Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting , 2021, Annals of Internal Medicine.

[6]  J. Zalcberg,et al.  Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysis , 2021, Health and Quality of Life Outcomes.

[7]  Xiaotong Han,et al.  Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery , 2021, Journal of Infection.

[8]  Henrik Nielsen,et al.  Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study , 2021, The Lancet Infectious Diseases.

[9]  Mark G. Jones,et al.  3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study , 2021, The Lancet Respiratory Medicine.

[10]  P. Nilsson,et al.  Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. , 2021, JAMA.

[11]  Rahul D. Pawar,et al.  Comparison between Patients Hospitalized with Influenza and COVID-19 at a Tertiary Care Center , 2021, Journal of General Internal Medicine.

[12]  C. Wolf,et al.  Sequelae in Adults at 6 Months After COVID-19 Infection , 2021, JAMA network open.

[13]  Benjamin Bowe,et al.  High-dimensional characterization of post-acute sequelae of COVID-19 , 2021, Nature.

[14]  Yongsheng Wu,et al.  Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study , 2021, The Lancet Microbe.

[15]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[16]  Paul J. Harrison,et al.  Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA , 2020, The Lancet Psychiatry.

[17]  P. Tubert-Bitter,et al.  Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study , 2020, The Lancet Respiratory Medicine.

[18]  I. Guessous,et al.  COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings , 2020, Annals of Internal Medicine.

[19]  V. Fan,et al.  Risk Factors for testing positive for SARS-CoV-2 in a national US healthcare system , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Hongjie Yu,et al.  The disease burden of influenza beyond respiratory illness , 2020, Vaccine.

[21]  F. Bruyère,et al.  Follow-up of adults with noncritical COVID-19 two months after symptom onset , 2020, Clinical Microbiology and Infection.

[22]  Davide Algeri,et al.  The Psychological and Social Impact of Covid-19: New Perspectives of Well-Being , 2020, Frontiers in Psychology.

[23]  Manoj Sivan,et al.  Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation , 2020, Journal of medical virology.

[24]  S. Kraus,et al.  Predictors of COVID-19 voluntary compliance behaviors: An international investigation , 2020, Global Transitions.

[25]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[26]  Lisa Rosenbaum.  The Untold Toll - The Pandemic's Effects on Patients without Covid-19. , 2020, The New England journal of medicine.

[27]  Andrew K. Przybylski,et al.  Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science , 2020, The Lancet Psychiatry.

[28]  J. Lee,et al.  Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors , 2019, Psychiatry investigation.

[29]  Alaa M Althubaiti,et al.  Information bias in health research: definition, pitfalls, and adjustment methods , 2016, Journal of multidisciplinary healthcare.

[30]  Arthur S Slutsky,et al.  One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. , 2007, Archives of internal medicine.

[31]  I. Hickie,et al.  Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study , 2006, BMJ : British Medical Journal.

[32]  M. Waern,et al.  Performance of the SF-36 Health Survey in screening for depressive and anxiety disorders in an elderly female Swedish population , 2005, Quality of Life Research.

[33]  C. Morin,et al.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research. , 2001, Sleep medicine.

[34]  Andrew C. Leon,et al.  Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability Scale , 1997, International journal of psychiatry in medicine.

[35]  M. Tamburini,et al.  Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. , 1996, European journal of cancer.

[36]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[37]  S. Wessely,et al.  Development of a fatigue scale. , 1993, Journal of psychosomatic research.

[38]  C K Wells,et al.  Evaluation of clinical methods for rating dyspnea. , 1988, Chest.

[39]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.